Targeted Delivery of Theranostic Agents
Application
US20260077071A1
Kind: A1
Mar 19, 2026
Inventors
Mohammad Haskali, Craig A. Hutton
Abstract
The present invention relates to compounds and methods for the targeted delivery of diagnostic/therapeutic radionuclides to cancer tissue. In particular, the present invention relates to the targeted delivery of diagnostic/therapeutic radionuclides to cholecystokinin-2 receptor positive cancers and to methods for the diagnosis and treatment of cancer.
CPC Classifications
A61K 51/088
C07B 59/008
C07K 7/08
A61K 2121/00
A61K 2123/00
C07B 2200/05
Filing Date
2023-03-16
Application No.
18847110